CN104367981A - Medicament for treating erysipelas - Google Patents

Medicament for treating erysipelas Download PDF

Info

Publication number
CN104367981A
CN104367981A CN201410648552.3A CN201410648552A CN104367981A CN 104367981 A CN104367981 A CN 104367981A CN 201410648552 A CN201410648552 A CN 201410648552A CN 104367981 A CN104367981 A CN 104367981A
Authority
CN
China
Prior art keywords
parts
medicine
radix
cornu cervi
myrrha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410648552.3A
Other languages
Chinese (zh)
Inventor
李�杰
张爱萍
黄结云
陈绍娟
黄志超
曾令城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410648552.3A priority Critical patent/CN104367981A/en
Publication of CN104367981A publication Critical patent/CN104367981A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating erysipelas. The medicament is characterized by consisting of the following components in parts by weight: 10-12 parts of cornu cervi degelatinatum, 10-12 parts of prepared rhizome of rehmannia, 10-12 parts of pericarpium zanthoxyli, 10-12 parts of ephedra herb, 10-12 parts of cassia bark, 10-12 parts of baked ginger, 10-12 parts of salvia miltiorrhiza, 10-12 parts of safflower, 10-12 parts of suberect spatholobus stem, 10-12 parts of frankincense, 10-12 parts of myrrh, 10-12 parts of Sichuan coptis, 10-12 parts of amur corktree bark and 10-12 parts of baical skullcap root. The medicament disclosed by the invention has the advantages of easily available raw material, low cost, significant treatment effect and the like.

Description

One treats erysipelas medicine
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.
Background technology
Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.
Through general retrieval, do not find the scheme identical with present patent application.
Summary of the invention
The object of the invention is to: propose one and treat erysipelas medicine.
Treatment erysipelas medicine of the present invention, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition.
Treatment erysipelas medicine of the present invention, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Treatment erysipelas medicine of the present invention, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
Treatment erysipelas medicine of the present invention, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Treatment erysipelas medicine of the present invention, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Chinese medicinal formulae of the present invention, treat many patients, now enumerate model case as follows:
Model case clinical effectiveness:
Just certain, male, 31 years old.Congestion and swelling pain 1 day inside left leg, companion's fever with aversion to cold, has a headache thirsty, body temperature 39.7 DEG C.Be diagnosed as acute lymphatic meshwork scorching.Give quiet of penicillin, oral cephalosporin treatment, medication 3 days heat is not moved back only, but shank redness is not moved back.Take treatment erysipelas Drug therapy of the present invention after 2 days, evanescence of heat is received good, and local redness disappears substantially.Take treatment erysipelas Drug therapy of the present invention 3 days and heal.

Claims (4)

1. a treatment erysipelas medicine, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition.
2. a treatment erysipelas medicine, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Pulverize, packaging, obtains product.
3. a treatment erysipelas medicine, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
4. a treatment erysipelas medicine, it is characterized in that: by weight, by Cornu Cervi Degelatinatum 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Fructus Zanthoxyli 10-12 parts, 10-12 parts, Herba Ephedrae, Cortex Cinnamomi 10-12 parts, Rhizoma Zingiberis Preparatum 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, 10-12 parts, Flos Carthami, Caulis Spatholobi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Rhizoma Coptidis 10-12 parts, Cortex Phellodendri 10-12 parts, Radix Scutellariae 10-12 parts composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
CN201410648552.3A 2014-11-14 2014-11-14 Medicament for treating erysipelas Pending CN104367981A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410648552.3A CN104367981A (en) 2014-11-14 2014-11-14 Medicament for treating erysipelas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410648552.3A CN104367981A (en) 2014-11-14 2014-11-14 Medicament for treating erysipelas

Publications (1)

Publication Number Publication Date
CN104367981A true CN104367981A (en) 2015-02-25

Family

ID=52547341

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410648552.3A Pending CN104367981A (en) 2014-11-14 2014-11-14 Medicament for treating erysipelas

Country Status (1)

Country Link
CN (1) CN104367981A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101028480A (en) * 2006-02-27 2007-09-05 权力敏 Erysipelas wash
CN101698080A (en) * 2007-12-18 2010-04-28 王春霞 Purple-flower holly leaf erysipelas lotion and equipment method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101028480A (en) * 2006-02-27 2007-09-05 权力敏 Erysipelas wash
CN101698080A (en) * 2007-12-18 2010-04-28 王春霞 Purple-flower holly leaf erysipelas lotion and equipment method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
王维编: "《中国验方全书》", 31 January 2006, 内蒙古科学技术出版社 *
罗和古等主编: "《经方验方巧治皮肤病.上册》", 31 August 2007, 中国医药科技出版社 *
郑锦章等: ""阳和汤加味治疗慢性丹毒17例"", 《辽宁中医杂志》 *

Similar Documents

Publication Publication Date Title
CN104435424A (en) Medicine for treating male climacteric syndrome
CN103356968B (en) Traditional Chinese medicine composition for treating endometriosis
CN103446554A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN104435252A (en) Medicine for treating acute mastitis
CN104383486A (en) Medicament for treating bronchitis of children
CN104367888A (en) Medicine for treating acute and chronic balanitis
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN104383485A (en) Medicine for treating infantile anorexia
CN111358906B (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN104027522A (en) Traditional Chinese medicament for treating acute appendicitis
CN104337989A (en) Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout
CN104367949A (en) Medicament for treating urinary calculus
CN104367951A (en) Medicine for treating prostate hyperplasia
CN104383046A (en) Medicament for treating infantile diarrhea
CN101912537A (en) Chinese medicinal preparation for treating cerebrovascular neuropathic pain
CN104367777A (en) Medicine for treating spermatorrhea
CN104383223A (en) Medicine for treating chicken pox in children
CN104367981A (en) Medicament for treating erysipelas
CN104436113A (en) Medicine for treating vomitus gravidarum
CN104436029A (en) Drug for treating pelvic inflammatory disease
CN104435313A (en) Medicine for treating haemorrhoids
CN104367730A (en) Medicine for treating postpartum urinary retention
CN104435350A (en) Drug for treating functional uterine bleeding
CN104474377A (en) Medicine for treating rheumatoid arthritis
CN104547441A (en) Medicine for treating tetanus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150225